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Abstract 
Lambs rely on maternal colostrum for immune protection since they are born 
immunodeficient. Research indicates that immunodeficiency at birth is required for the 
development of immune tolerance of commensal microbiota. Furthermore, the role between 
commensal microorganisms and host interaction supports that commensals play a role in immune 
training, but work regarding the role of commensal microbiota in immune development in 
ruminants is minimal. Even with support from maternal immunoglobulin, lambs exhibit high 
mortality rates, so implementing early and effective vaccination schedules for disease prevention 
is important. Unfortunately, this has not been well-studied. 
In this experiment, we investigated whether treatment with probiotics could enhance 
immune response in lambs. Lambs received probiotics weekly beginning at two days old, and 
then were vaccinated with keyhole limpet hemocyanin (KLH) at either 2, 16, or 30 days after 
birth, followed by a booster 2 weeks later. Blood samples were collected immediately prior to 
vaccination on sample day (SmplD 0), at booster two weeks later (SmplD 14), and two weeks 
after the booster vaccination (SmplD 28). Serum was isolated and anti-KLH specific IgG and 
IgM production was assayed by ELISA. 
Statistical analyses indicated significant differences for vaccination age and sample time. 
Levels of anti-KLH specific IgG increased with age, supporting that older animals can generate 
stronger IgG specific immune responses. Additionally, significant differences in sample time 
showed increased levels of IgM production after the primary vaccination and further increased 
IgM levels after the booster vaccination. Although not statistically significant, general trends 
indicated that probiotics might enhance immune response in 30-day old lambs. 
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Literature Review 
Reducing mortality rates of lambs increases profitability of both large- and small-scale 
sheep farming operations. Mortality rates of lambs born alive range from 9 to 32% (Dalton et al., 
1980; Daniels et al., 2000; Dawson & Carson, 2002; Hight & Jury, 1970; Hulet et al., 1987; 
Johnston et al., 1999; Matos et al., 2000; Oltenacu & Boylan, 1981; Scales et al., 1986) and is 
higher for twins and triplets. Reducing mortality, especially by vaccinating young, susceptible 
animals as early and effectively as possible is important to the farmer’s ability to run a 
monetarily successful business that incorporates appropriate animal welfare practices. 
Passive immunity derived from maternal colostrum plays a critical role in early immune 
protection in immunocompetent animals (De La Rosa et al., 1997; Hunter et al., 1977; Nowak & 
Poindron, 2006; Sawyer et al., 1977; Tizard, 1987). However, maternal antibodies may also 
interfere with vaccinations and the development of an independent, protective neonatal immune 
response (De La Rosa et al., 1997; Mutwir et al., 2000). While independent immunocompetence 
increases as an animal’s age increases, there is also a marked decline in passive immunity 
derived from the mother, allowing for a window of susceptibility to disease that is generally 
targeted as the proper time to vaccinate (Chase et al., 2008). 
Recent research has indicated that the importance of immune development in neonates 
centers around the necessity of immune system development to distinguish commensal 
microbiota from pathogenic bacteria (Belkaid and Hand, 2014). Commensal microbiota has 
proven critical for immune function in studies with germ-free mice, particularly in training the 
immune system to distinguish commensal microbiota from pathogenic bacteria. Initiation and 
maintenance of proper immune responses to pathogens is highly dependent on communication 
between the mucosal immune system and commensal bacteria (Belkaid and Hand, 2014). In the 
mucosal immune system, commensal organisms also benefit the host by competing with 
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pathogens for adhesion sites and decreasing the amount of nutrients available to pathogenic 
organisms (Abd El-Tawab et al., 2016). Early microbiota seeding in neonates begins with 
exposure to maternal commensal bacteria in the vaginal canal and continues to build and 
diversify in repertoire through all interactions with the environment and other animals, as well as 
food and water resources. 
Probiotics, which refer to commensal microbacterial supplement/additive, have long been 
associated with increased health and feed efficiency in ruminants. Probiotics largely consist of 
lactic acid bacterial microorganisms. Multiple studies have shown the protective roles that these 
microorganisms play in regulating intestinal transit, gut barrier reinforcement, colonization 
resistance, vitamin synthesis, downregulation of Th2 immune responses, and development of 
both innate and adaptive immune function (Zimmermann & Curtis, 2017; Wu et al., 2016). 
Although researchers have noted the potential of probiotics for increasing vaccination 
success, the route of administration of vaccine and probiotics, as well as probiotic strain type and 
dosage, play a critical role in increasing efficacy of vaccines as documented in humans 
(Zimmermann & Curtis, 2017). Thus, early probiotic administration has the potential to increase 
early immune response in neonatal lambs, but research with probiotics in small ruminants has 
mainly focused on probiotic’s effect on acceleration of growth rather than immune development. 
Studies investigating the generation of specific immune responses in lambs have had 
varied results. In one study, lambs vaccinated at five months of age showed higher and more 
persistent antibody response than animals vaccinated at fifteen days, while lambs vaccinated at 
fifteen days of age could not sustain a cytokine response (Corpa et al., 2000). Lambs vaccinated 
with ovalbumin at 1 and 15 days of age displayed short-lived antibodies between days 7 and 21 
followed by a marked decrease in antibody titers. Similarly, lambs vaccinated with ovalbumin at 
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28 and 42 days developed antibody titers that increased until 21 days after inoculation and then 
decreased (Lewis et al., 2017). 
Other research has shown that neonatal lambs can generate independent immune 
responses, but the responses are highly dependent on dose of antigen, type of adjuvant, and the 
type of antigen presenting cell. One example was that the enteric immunization of newborn 
lambs induced both humoral and cell-mediated mucosal immune responses, although the 
ELISpot and gD-specific assays used displayed higher titers in five to six-week-old lambs 
(Mutwiri et al., 2000). Similarly, lambs vaccinated with KLH at 0 weeks generated anti-KLH 
Ab, but higher levels of Ab production were evident in older lambs (Gailor, 2007). Some 
researchers reported that young lambs were incapable of generating immunological memory 
(Corpa et al., 2000; Lewis et al., 2017) 
Keyhole lymphocyte hemocyanin (KLH) is a common antigen used in immune-based 
studies because it has well documented immunostimulatory properties in humans and animals 
(Harris & Markl, 1999). Antigens are substances recognized by the host immune system as non-
self. KLH is respiratory protein found in a marine mollusk, so it is foreign to passive, maternally 
derived immunoglobulins and complex enough to stimulate immune responses in lambs. 
Enhancing complexity and degree of foreignness increase individual immune responses 
to antigens. A common approach to enhance immune responses to an antigen is by linking 
antigen to an adjuvant. Adjuvants linked to antigens in vaccines increase the complexity of the 
antigen and thus, immunogenicity, allowing for stronger, more sustained immune responses 
(Coffman et al., 2010). A common adjuvant, and the adjuvant used in this experiment, is alum, 
an aluminum hydroxide and magnesium hydroxide-based adjuvant. While little is known about 
the mechanism of action associated with adjuvants, besides their role in inducing and 
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maintaining a strong humoral response, recent studies have demonstrated that aluminum 
hydroxide plays an important part in establishing memory responses by stimulating macrophage 
activation, in addition to myeloid dendritic cells (Rimaniol et al., 2004). 
Vaccines act to introduce novel antigens to stimulate immune cells. Macrophages ingest 
and display antigen(s) on major histocompatibility complex (MHC) molecules. T cells 
recognizes novel antigen(s) on the MHC and stimulate B cells to produce antibodies specifically 
for each antigen (Institute of Medicine, 1997; Day, 2007). The first time a host immune system 
recognizes and generates an immune response to an antigen is called the primary immune 
response. Generally, cytokines (soluble mediators) influence which isotype of immunoglobulin 
the B cells generate, but the antibody secreted in the primary immune response is IgM. This 
antibody is a pentamer with 10 antigen binding sites. When an immune response to an antigen is 
terminated, memory cells are formed. When an individual receives a booster vaccination, the 
antigen triggers memory cells to activate plasma B cells which secrete high levels of antibody 
that already have specificity for that antigen from the primary immune response for rapid 
clearance of antigen. The antibody primarily secreted in the secondary immune response to 
vaccination is IgG which contains multiple subtypes and has greater ability to bind and clear 
antigen (Institute of Medicine, 1997). 
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Introduction 
While sheep were some of the first animals to be domesticated by humans, their 
relevance for providing both clothing fiber and meat has decreased in the United States since 
1945. There are multiple explanations for this decline, but high lamb mortality is one of the 
major reasons (Jones, 2004). 
Antibody-rich colostrum is paramount for early immune function in lambs. Vaccination 
of ewes prior to lambing insures that neonates receive passive immunity to diseases common in 
young lambs, like enterotoxaemia (De La Rosa et al., 1997). Variation of the amount of 
colostrum received, and genetic factors in the ewe can result varied amounts of antibody 
providing passive immunity for lambs (De La Rosa et al., 1997; Hernández-Castellano et al., 
2014) These findings demonstrate the importance of establishing independent 
immunocompetence as quickly as possible to promote lamb health. However, studies 
investigating the development of the lamb immune system have reached varied conclusions. 
While some researchers have demonstrated immunocompetence in lambs as early as two days of 
age (Gailor, 2007; Mutwiri, Bateman, Baca-Estrada, Snider, Griebel, et al., 2000), others 
observed a lack of immunological memory in young lambs (Corpa et al., 2000; Lewis et al., 
2017). 
Recent research has suggested a possible role for commensal bacteria in early immune 
development in neonates (Abd El-Tawab et al., 2016; Bauer et al., 2006; Isolauri et al., 2001; 
Perdigon et al., 1995; Roos et al., 2010). Thus, while maternal antibodies provide a basic 
immune system to defend against known pathogens, the immune system of the young animal 
develops and learns to tolerate commensal microbiota that play a varied and important role in 
both mucosal and systemic immune function (Abd El-Tawab et al. 2016; Bauer et al. 2006; 
Belkaid and Hand 2014). This suggests that increasing early gastrointestinal tract colonization by 
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commensal microbiota or modulating the populations of organisms in the gut could modulate 
immune response in neonates, possibly even improving them. 
The purpose of this experiment was to begin to identify the age at which lambs are first 
capable of generating an immune response and immunological memory to specific pathogens 
and to determine if weekly probiotic administration would influence this response. This 
information could contribute to strategies to decrease mortality in lambs. As globalization 
continues, the value of lamb, mutton, and wool in many cultures around the world will become 
more important. Additionally, there is likely to be increased consumer preference for meat that is 
more environmentally friendly than beef. This suggests that there is an opportunity for the sheep 
industry to grow in the United States. Further characterization of the lamb immune system would 
allow for the development of successful vaccination regimens, thus preventing diseases and 
decreasing mortality rates. Decreasing mortality rates would fundamentally improve animal 
welfare and increase profitability of farms. 
Materials and Methods 
Experimental Animals 
Lambs in this experiment were born starting on October 30, 2017 and sired by ½ East 
Friesian x ¼ Dorset x ¼ Tunis rams and out of Finnsheep x Dorset or Dorset ewes. Lambs were 
artificially reared on the cold-milk lambar system (see appendices for specific lamb birthdates 
and sampling dates). Prior to any lambs being born in the fall lambing of 2017, they were 
assigned by birth order randomly to treatment groups to ensure that all treatment groups would 
include a minimum of 2 lambs. Additional lambs were assigned as controls (Table 1). 
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Table 1. Design of experiment using keyhole lymphocyte (KLH) antigen1. 
Probiotic Vaccine 
Initial vaccination age Control Adjuvant Adjuvant + KLH 
No probiotic - - - - - - - - - - - - Number of lambs - - - - - - - - - - - - -  
2 days 1 2 2 
16 days 1 2 2 
30 days 0 3 2 
Probiotic    
2 days 1 2 2 
16 days 1 2 2 
30 days 0 2 2 
1Blood was collected from each lamb prior to initial vaccination (SmplD 0), prior to the 
booster 14 days later (SmplD 14)), and 14 days after the booster (SmplD 28). 
 
Lambs were assigned to one of two probiotic groups (none or probiotic). Probiotic 
(Probios Bovine Oral Gel for Ruminants at not less than 10 million CFU2/g) contained lactic 
acid bacteria (enterococcus faecium, lactobacillus acidophilus, lactobacillus casei, and 
lactobacillus plantarem). Lambs receiving probiotic were administered five grams at two days of 
age. Subsequent dosing of probiotics occurred on the same day of the week (Monday) for 
convenience during the experiment. Five grams of probiotics were administered to lambs when 
they were between days 2 and 15 of age, 10 grams between days 16 and 29 of age, and 15 grams 
from day 30 until completion of the experiment. Increasing dosage was to account for increasing 
weight of lambs. 
The probiotic and no-probiotic lambs were distributed among 3 vaccination groups 
(control, adjuvant only, or adjuvant + KLH antibody), and 3 ages of initial vaccination (2, 16, 
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and 30 days) as shown in Table 1. Each lamb received the vaccination protocol to which it was 
assigned and was boosted 14 days later. Blood samples were collected prior to initial vaccination 
(SmplD 0), prior to booster (SmplD 14), and at 28 days after initial vaccination (SmplD 28). 
Preparation of KLH Vaccine 
To prepare the KLH vaccine, KLH, keyhole lymphocyte hemocyanin (Calbiochem) was 
dissolved in sterile phosphate buffered saline (PBS) to 10 mg/mL stock solution. For 
vaccination, 0.25 mg of KLH in a total volume 250 µL of PBS was mixed with 250 µL Imject 
Alum (Thermo Fisher), an aluminum hydroxide and magnesium hydroxide-based adjuvant. 
Imject was added dropwise with constant mixing to the KLH for final ratio of 1:1. The KLH 
alum solution was rocked on a medium speed rocker for thirty minutes before administration or 
refrigeration. If refrigerated, the vaccine solution was remixed by shaking prior to 
administration. Lambs were given the vaccine at the age that corresponded with their assigned 
start date (either 2, 16, or 30 days of age) and then received a booster vaccine two weeks later. 
 For each vaccination and booster, lambs received 500 µL. The lambs in groups assigned 
to receive adjuvant alone were given 250 µL Imject Alum mixed with 250 µL of PBS-prepared 
as described above. Both were administered to lambs by subcutaneous injection immediately 
following blood sample collection. 
Blood Collection and Storage 
Blood was collected from the jugular vein immediately prior to initial vaccination 
(SmplD 0) and the booster vaccination (SmplD 14). A final sample was obtained two weeks after 
the booster (SmplD 28). Blood was refrigerated overnight to allow it to clot and then centrifuged 
at 3,000 rpm for 15 minutes. Serum was removed and stored at -20ºC. 
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ELISA Assay 
 Anti-KLH IgM and IgG Ab levels were determined by ELISA. Briefly, the wells of 
Immulon 1 (VWR) microtiter plates were coated with 50 µL KLH diluted to 0.5 mg/well in 
carbonate buffer pH 9.6 and incubated overnight at 4ºC. The plates were then washed twice with 
150 µL/well with PBS-1% Tween-20 pH 7.4, followed by two washes with 150 µL/well PBS pH 
7.4. Non-specific binding to the wells was blocked by the addition of 50 µL/well PBS containing 
1% BSA for one hour at room temperature. The plates were then washed as above and 50 µl of 
serum diluted in PBS with 0.1% Tween-20 pH 7.4 four-fold starting at 1:40 to 1:2560 was added 
to the wells in duplicates. The plates were covered with parafilm and incubated overnight at 4ºC. 
The plates were washed as above, and then 50 µL rabbit anti-sheep anti-IgM conjugated to 
horseradish peroxidase (HRP) (1:10,000 in PBS-0.1% Tween-20) or rabbit anti-sheep anti-IgG 
conjugated to HRP (1:9,000 in PBS-0.1% Tween-20) was added to each well. Both antibodies 
were obtained from BioRad. After addition of the rabbit anti-sheep Ig-HRP detector antibodies, 
the plates were covered with parafilm and then incubated at room temperature for two hours. 
Then, plates were washed as above and 50 µL of TMB substrate (Thermo Fisher) was added to 
the wells and the plates were incubated in the dark for thirty minutes. Color development was 
stopped with 2 M sulfuric acid, and the absorbance–corresponding to the amount of substrate– 
was read at 450 nm using a SpectraMax 190 ELISA Reader, equipped with Soft Max Pro 6.5.1 
software (Molecular Devices). 
Statistical analysis 
Response variables included ELISA IgM and IgG optical densities with samples diluted 
1:160 and the natural log transformed values for the reciprocal of the titer values (Reverberi, 
2008). The statistical model included main effects of Probiotic, Vaccination, Vaccination Age, 
and Sampling Days relative to initial vaccination. All possible interactions were included. Lamb 
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within Probiotic, Vaccination, and Vaccination Age (with 13 degrees of freedom) was included 
as a random effect to test main effects of Probiotic, Vaccination, and Vaccination Age and their 
interactions. Residual variation (with 26 degrees of freedom) was used to test Sampling Day and 
all of its associated interactions. 
Results 
Effects of probiotic on the production of anti-KLH IgM after vaccination 
We compared the production of anti-KLH IgM in 2-day old lambs that had received 
probiotics or not and were vaccinated at 2 days of age, and then received a booster vaccine at 16 
days of age. Probiotic-treated lambs had received one dose at the time of vaccination. Serum 
samples were obtained immediately prior to vaccination (SmplD 0), immediately prior to booster 
vaccination (SmplD 14), and 14 days after that (SmplD 28). Serum was measured for levels of 
anti-KLH IgM in a direct ELISA. The results are shown in Figure 1. All sera from treatment and 
control groups were diluted 1:160 and the level of bound anti-KLH IgM, corresponding to the 
absorbance at 450 nm, was determined. As expected, the levels of anti-KLH IgM antibodies 
were increased at SmplD 14 and SmplD 28, after the first and second immunizations 
respectively, compared to SmplD 0. 
Probiotic administration had no significant effect on the levels of anti-KLH specific IgM 
antibodies produced in 2-day old lambs compared with lambs that did not receive probiotics.. 
However, there was a trend toward higher levels at SmplD 14 in lambs that had received 
probiotics compared with lambs that had not received probiotics at the same timepoint. In both 
probiotic groups, the levels of anti-KLH IgM produced at SmplD 28 were slightly lower than at 
SmplD 14 but still increased compared to the levels that were produced at SmplD 0.  
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Figure 1. Levels of anti-KLH IgM Ab in lambs initially-vaccinated at 2-days of age. Data are 
expressed as mean OD 450 nm, corresponding to levels of anti-KLH IgM antibodies. Bars represent 
standard deviations. 
 
We next determined levels of anti-KLH IgM in 16-day old lambs that had received either 
probiotics or not, vaccinated initially at 16 days of age and then received a booster vaccine at 30 
days of age. Serum samples (from SmplD 0, 14, and 28 after initial vaccination) were measured 
for anti-KLH IgM by ELISA as described above, and the results are shown in Figure 2. At 16 
days of age, the lambs had received two doses of probiotics. Like the data for 2-day old lambs, 
we found that probiotics did not modulate the production of anti-KLH specific IgM Abs in lambs 
that were vaccinated at 16 days of age. Relatively high ODs were recorded at SmplD 0 in both 
probiotic-treated and untreated lambs, which may be due to non-specific binding of serum 
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proteins. Absorbances for SmplD 14 samples were slightly lower than for SmplD 0, but similar 
for probiotic or non-probiotic treated animals. SmplD 28 samples showed increased ODs in 
animals that had not received probiotics, however there was variability in individual samples as 
indicated by large standard deviation bars (Figure 2).  
 
Figure 2. Levels of anti-KLH IgM Ab in 16-day-old lambs. Data are expressed as mean OD 450 
nm, corresponding to levels of anti-KLH IgM antibodies. Bars represent standard deviations. 
 
We also compared the production of anti-KLH IgM in 30-day old lambs that had received 
either probiotics or not, blood-sampled and vaccinated at 30 days of age (SmplD 0), and then 
blood-sampled and received a booster vaccine at 44 days of age (SmplD 14) and blood-sampled 
at 48 days of age (SmplD 28). Lambs that were 30 days old had received four doses of 
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probiotics. SmplD 0, 14, and 28 serum samples were measured for anti-KLH IgM by ELISA as 
described above, and the results are shown in  
Figure 3. In contrast to the results for 2- and 16-day old lambs, lambs that had received 
probiotics and then were vaccinated at 30 days of age showed a trend toward an improved 
immune response, with increased production of anti-KLH specific IgM antibodies in probiotic-
treated lambs compared with lambs that had not received probiotics at SmplD 0 and SmplD 14, 
and lower but still slightly higher than non-probiotic treated lambs at SmplD 28 (Figure 3). 
 
Figure 3. Levels of anti-KLH IgM Ab in 30-day-old lambs. Data are expressed as mean OD 
450 nm, corresponding to levels of anti-KLH antibodies. Bars represent standard deviations. 
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Effects of probiotic on the production of anti-KLH IgG after vaccination 
The production of anti-KLH IgG in 2-day old lambs that had received either probiotics or 
not and were vaccinated at 2 days of age, and then received a booster vaccine at 16 days of age 
was determined. Lambs had received one dose of probiotics. Serum samples at SmplD 0, 14, and 
28 were measured for anti-KLH IgG levels by ELISA and the results are shown in Figure 4
 
Figure 5. All sera from treatment and control groups were diluted 1:160 and the level of 
bound anti-KLH IgG was measured, corresponding to the absorbance at 450 nm. While no 
significant differences  
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Figure 4. Levels of anti-KLH IgG Ab in 2-day-old lambs. Data are expressed as mean OD 450 
nm, corresponding to levels of anti-KLH antibodies. Bars represent standard deviations. 
 
were detected, there was a trend toward lower levels of anti-KLH IgG antibodies in lambs in 
treated with probiotics compared to non-probiotic treated lambs. This trend was also observed on 
SmplDs14 and 28. Lambs that did not receive probiotics maintained higher anti-KLH IgG Ab 
levels overall compared to lambs that received probiotics. 
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Figure 5. Levels of anti-KLH IgG Ab in 16-day-old lambs. Data are expressed as mean OD 
450 nm, corresponding to levels of anti-KLH antibodies. Bars represent standard deviations. 
 
The levels of anti-KLH IgG in 16-day old lambs that had received either probiotics or not 
and were vaccinated at 16 days of age with a booster at 30 days of age are shown in Figure 5. 
SmplD 0, 14, and 28 serum samples were measured in a direct ELISA as described as above. 
SmplD 0 samples for both probiotic and non-probiotic groups showed higher than expected but 
similar absorbance levels for both probiotic groups, which likely was due to non-specific binding 
or interactions of serum proteins with ELISA wells. The absorbance of serum samples from 
SmplD 14 was decreased in lambs that received probiotics but slightly increased in lambs that 
did not receive probiotics. Absorbances at SmplD 28 were increased for both probiotic-treated 
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and untreated lambs, with the lambs that had not received probiotics showing a trend to higher 
absorbance levels.  
 
Figure 6. Levels of anti-KLH IgG Ab in 30-day-old lambs. Data are expressed as mean OD 450 nm, 
corresponding to levels of anti-KLH antibodies. Bars represent standard deviations. 
 
Data for 30-day old lambs that had received either probiotics or not and were vaccinated 
at 30 days of age followed by a booster 14 days later are shown in Figure 6. A direct ELISA as 
described above was used to determine anti-KLH IgG levels in serum samples taken at SmplD 0, 
14, and 28. At 30 days of age, the lambs had received four doses of probiotics. At SmplD 0, the 
absorbance level was lower in lambs that had received probiotics compared to lambs that had not 
received probiotics, while at SmplD 14 there were similar levels of anti-KLH specific IgG were 
in both probiotic groups. While there was variation in the level of antibody at SmplD 28 in both 
groups, as shown by the relatively large standard deviations, there was a trend toward increased 
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levels of production of anti-KLH specific IgG in lambs that had received probiotics, and 
relatively decreased, or perhaps less enhanced, anti-KLH specific IgG levels in lambs that had 
not received probiotics. 
Statistical Analysis of the Data 
The summary of the statistical analyses of the data is in Table 2 . There were differences 
in anti-KLH IgG levels that depended on the age of the lambs at vaccination (Vaccination age x 
Sample time interaction, P < 0.001). While statistical analyses did not detect a significant effect 
of probiotic on the levels of anti-KLH specific IgM or IgG produced by lambs vaccinated at any 
age in this experiment, the trends in the data indicate that probiotic treatment may modulate the 
immune response, suggesting that further investigation in a larger study is warranted. 
Interestingly, when IgM binding to KLH over time was compared for the 2, 16 and 30-
day old animals, much a lower absorbance reading was observed in the 2-day lambs compared to 
the 16 and 30-day old animals, that showed relatively high absorbance at SmplD 0 (Figure 7). 
Higher absorbance indicates greater specific antibody binding within the individual ELISA 
wells. This difference in the kinetics of the antibody response was not unexpected, since the 
immune system of newborn lambs is immature and develops as the animals age. Sex and breed 
differences may also contribute to differences in immune responses among the lambs. 
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Table 2. Effect of probiotic and vaccination on serum concentrations of IgM and IgG 
antibodies to KLH in lambs vaccinated at 2, 16, and 30 days of age and sampled at 0, 14 
(booster given), and 28 days after vaccination. 
 
Optical density 
read at 450 nm and 
at 1:160 dilution 
 
IgM  IgG 
Item IgM  IgG 
 
ln 
Geometric 
mean  ln 
Geometric 
mean 
Probiotic 
       
No 0.87 
 
0.67 
 
7.28 1451 
 
6.50 665 
Yes  0.93 
 
0.60 
 
7.35 1556 
 
6.50 665 
SE 0.045 
 
0.034 
 
0.158 
  
0.280  
P-value 0.402 
 
0.151 
 
0.775 
  
1.000  
Vaccination 
        
 
Adjuvant 0.95 
 
0.63 
 
7.44 1703 
 
6.50 665 
Adjuvant + KLH 0.85 
 
0.64 
 
7.19 1326 
 
6.50 665 
SE 0.046 
 
0.034 
 
0.158 
  
0.280  
P-value 0.143 
 
0.883 
 
0.287 
  
1.000  
Vaccination age, days 
2 0.92 
 
0.67 
 
6.57699 718 
 
6.92 1012 
16 0.98 
 
0.51 
 
7.84776 2560 
 
6.11 450 
30 0.81 
 
0.71 
 
7.52044 1845 
 
6.46 639 
SE 0.05 
 
0.042 
 
0.193 
  
0.342  
P-value 0.132 
 
0.011 
 
0.001 
  
0.280  
Sample day, days from vaccination 
0 0.86 
 
0.59 
 
6.51923 678 
 
6.46 639 
14 0.93 
 
0.64 
 
7.63597 2071 
 
6.27 528 
28 0.92 
 
0.67 
 
7.79000 2416 
 
6.77 871 
SE 0.043 
 
0.030 
 
0.142 
  
0.311 
 
P-value 0.289 
 
0.076 
 
< 0.001 
  
0.493 
 
Vaccination age 
X Sample day 
ns  ns  < 0.001   
ns 
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Figure 7. Effect of vaccination age on the relationship of the IgM titer to days after vaccination. 
Lambs received the first dose of vaccine on SmplD 0, and a booster vaccine on SmplD14 after the 
initial vaccination. 
 
 
Discussion 
The purpose of this experiment was to begin to define the age at which lambs are first 
capable of generating an immune response and immunological memory to specific pathogens 
and to determine if weekly probiotic administration would influence this response. Time of 
initial vaccination combined with time after vaccination influenced the production of anti-KLH- 
specific IgM in lambs vaccinated with KLH in alum adjuvant (Table 2). Our observation that 2-
day old lambs were immunocompetent, but that as animals aged the immune system matured 
with increasing immune function, is in agreement with prior research (Chase et al., 2008; Corpa 
et al., 2000; Gailor, 2007; Lewis et al., 2017; Mutwiri et al., 2000). 
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In the present experiment, lambs received maternal colostrum during the first twenty-four 
hours of life. While this is a common and critical management practice used in sheep operations 
it likely contributed to some of the variability in our data. Individual ewes could produce 
different amounts and quality of colostrum, resulting in differences in the levels of circulating 
antibodies and colostrum-dependent proteins in the individual lambs. Other researchers have 
found that colostrum was necessary for increased plasma concentration of apolipoprotein A-IV, 
plasminogen, serum amyloid A, and fibrinogen levels, most of which are proteins with immune 
functions (Hernández-Castellano et al., 2014). In the present experiment, we would not have 
expected ewes to provide lambs with specific antibody protection against KLH since they did not 
receive the vaccine, but nonspecific Ab interaction and binding of colostrum-derived proteins 
might have contributed to the higher than anticipated absorbance reading for control and 
adjuvant lambs as well as in the SmplD 0 serum samples (see Figures 1-6; data not shown for 
adjuvant and control lambs). Additionally, soluble mediators such as cytokines, adipokines, or 
complement components produced during the innate immune response to vaccination might also 
have contributed to higher than expected absorbance values. 
Although not statistically significant, we saw trends in an influence of probiotics on anti-
KLH IgM and IgG production in animals vaccinated at 16 and 30 days of age, which would have 
received two and four doses of probiotics respectively, suggesting that as beneficial organisms 
become established in the gastrointestinal tract, they may contribute to enhanced immune 
responses. In nature, colonization of the gastrointestinal tract of lambs begins in the birth canal 
with commensal organisms unique to the ewe. While the ewes in this experiment were the 
similar breeds and housed under the same conditions, it is likely that lambs started life with a 
different and individual microbiota repertoire based on commensal organisms unique to their 
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dam, which may also have contributed to some of the variability that we observed in SmplD 0 
serum samples. In this experiment, lambs received weekly doses of probiotics from birth, and 
just as natural microbial colonization takes time to become established, artificial colonization 
with probiotics containing bacterial strains would likely take some time to equilibrate and 
establish in the gut so that any potential beneficial effects on immune function may not be 
observed until that occurs (Roos et al., 2010; Wu et al., 2016). 
IgM is synthesized in newborns shortly after birth and is followed several weeks later by 
the production of IgG. The ability to newly synthesize IgA and antibodies of other isotypic 
classes occurs even later. The results of the present experiment also showed that a lamb’s ability 
to synthesize antigen-specific immunoglobulin increased as it aged. The trends that we observed 
in the production of anti-KLH IgG by 2, 16 and 30-day lambs receiving probiotics suggests that 
probiotics may help to increase the ability of the lamb immune system to produce antigen-
specific IgG at an earlier age and/or at higher titers compared to animals that do not receive 
probiotics. This is in agreement with previous studies, which in addition, found that the effect of 
probiotics on vaccine efficacy was also dependent upon the bacterial strain of probiotic used, the 
number of doses of probiotic that were administered, and the timing of probiotic administration 
relative to vaccination (Zimmermann & Curtis, 2018). The route of vaccination was also critical, 
with probiotic treatment having a greater effect on the production of immunoglobulin in response 
to an oral vaccine compared to the production of immunoglobulin when a vaccine to the same 
antigen was administered subcutaneously. Thus, probiotics will likely have different effects on 
antibody production after vaccination and in natural infection, but the mechanisms that are 
involved remain largely unknown (Kukkonen et al., 2006; Zimmermann & Curtis, 2018). 
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We also found that, while anti-KLH IgM levels were high and unchanged in all samples 
from 16 and 30-day old lambs, SmplD 0 levels in 2-day old lambs were low, but then increased 
at the later time points. We assumed that none of the sheep in this experiment would previously 
have been exposed to the KLH antigen. Therefore, anti-KLH IgM levels also should have been 
low at SmplD 0 in lambs first vaccinated at 16 and 30 days of age. Perhaps, because the lambs 
were all kept in the same pen, lambs first vaccinated at 16 and 30 days of age had been exposed 
to the KLH antigen after the 2-day old lambs were vaccinated. 
The lower levels at SmplD 0 in the 2-day old lambs might be that these lambs would 
have higher levels of circulating maternal antibody compared to the older lambs. The maternal 
antibody may have interfered with the ability of the 2-day old lambs to respond to the KLH 
vaccine by masking antigenic epitopes on KLH and/or down-modulating B cell function by 
blocking B-cell signaling (Nowak & Poindron, 2006; Sawyer et al., 1977). Another difference, as 
discussed previously, might also be the differences in the microflora of the younger lambs.  
There were also sex and slight breed differences among lambs that may have impacted 
individual lambs’ abilities to mount an immune response. Sex steroids have been shown to 
directly impact immune function and development, and in humans, estradiol provides an 
immune-protective role while testosterone is more immunoinhibitory. Both steroid hormones are 
thought to function in a similar manner in sheep, leading to sex differences in immune responses 
(Giefing-Kröll et al., 2015) . In the present experiment, because of the limited numbers of lambs 
that were available, both male and female lambs were used, and assigned randomly before birth 
to the treatment groups. In the older lambs, increased levels of these hormones could also have 
affected the immune response to KLH.  
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Genetic differences in the major histocompatibility complex (MHC) among the lambs 
may have impacted the immune response to KLH because they were sired by crossbred rams that 
were ½ East Friesian x ¼ Dore x ¼ Tunis breeds. Breed purity inherently results in limited 
genetic heterozygosity at MHC loci and results in differences in ability to mount specific 
immune response between breeds (Day, 2007). Presentation of antigen bound to MHC on 
antigen-presentation cells is required to activate T cells in the adaptive immune response that 
results in the production of antibody. Thus, different genetic backgrounds of the lambs may have 
had an impact on immunoglobulin production (Day, 2007). To account for these variables, future 
studies should include larger numbers of animals of the same sex and genetic background, if 
possible. 
Finally, the probiotic that was used in this experiment was a commercial preparation that 
contained mainly lactic acid bacteria species, which have been shown to promote a Th1cytokine 
response and inhibit intestinal Th2 cytokine responses (Wu et al., 2016). The humoral immune 
response, which includes the production of antibodies, is mainly Th2 cytokine-driven. We chose 
to use Alum as an adjuvant in this experiment as there is a large body of data supporting that it 
skews immune responses to Th2 cytokine and antibody production (Coffman et al., 2010). 
However, other research has shown that Alum can stimulate both Th1 and Th2 immune 
responses (Brewer et al., 1999). Consequently, the differences in the cytokine profiles induced 
by the probiotics and the adjuvant may also have influenced antibody production. 
Conclusion and Future Directions 
In this pilot experiment, we found that antigen-specific antibody titers that develop after 
vaccination were affected by the age at vaccination and time after vaccination. Trends in the data 
pointed to the possibility that probiotic administration could lead to earlier and higher levels of 
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specific antibody production. This should be explored further. The data also suggested that more 
rapid establishment of the probiotic populations in the GI tract could enhance the beneficial 
effects of these populations on immune function. For example, early and perhaps larger and/or 
more frequent dosing with probiotics could have a positive effect, but the time, cost and 
management issues required to implement this into general lamb flock management might be 
prohibitive. 
Future studies could also include analysis of probiotic impact on immune function in 
colostrum-deprived lambs. This would be extremely interesting because it could suggest ways to 
enhance the immunocompetence of these lambs and provide a unique look at immune system 
development in the absence of maternal Ab or protein interactions. Other studies could 
investigate immunomodulatory capabilities of different species and strains of commensal 
organisms to assess their potential to increase the overall immune response in lambs, in addition 
to antibody production. 
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